UroGen Pharma Ltd (Symbol: URGN) options are showing a volume of 20,539 contracts thus far today. That number of contracts represents approximately 2.1 million underlying shares, working out to a sizeable 192% of URGN's average daily trading volume over the past month, of 1.1 million shares. Particularly high volume was seen for the $24 strike call option expiring February 20, 2026, with 10,010 contracts trading so far today, representing approximately 1.0 million underlying shares of URGN. Below is a chart showing URGN's trailing twelve month trading history, with the $24 strike highlighted in orange:
And Design Therapeutics Inc (Symbol: DSGN) options are showing a volume of 5,000 contracts thus far today. That number of contracts represents approximately 500,000 underlying shares, working out to a sizeable 164.8% of DSGN's average daily trading volume over the past month, of 303,390 shares. Especially high volume was seen for the $9 strike call option expiring January 16, 2026, with 5,000 contracts trading so far today, representing approximately 500,000 underlying shares of DSGN. Below is a chart showing DSGN's trailing twelve month trading history, with the $9 strike highlighted in orange:
For the various different available expirations for UTHR options, URGN options, or DSGN options, visit StockOptionsChannel.com.
Today's Most Active Call & Put Options of the S&P 500 »
Also see:
PFG Dividend Growth Rate BRTX Insider Buying
Institutional Holders of MFCB
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.